Basic Information
ID: ALA835611
Type: Binding
Description: Efficacy against human PPARgamma expressed in HepG2 cells relative to rosiglitazone
Format: BAO_0000219
Organism: Homo sapiens
Cell type: HepG2
Target: Peroxisome proliferator-activated receptor gamma(ALA235)
Document: ALA1145171
Efficacy against human PPARgamma expressed in HepG2 cells relative to rosiglitazone: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA835611
Efficacy
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 357.44 | 2.49 | 2.49 |
| 214.65 | 2.58 | 2.58 |
| 310.27 | 3.78 | 3.78 |
| 272.30 | 2.77 | 2.77 |
| 292.33 | 3.91 | 3.91 |
| 318.37 | 4.43 | 4.43 |
| 270.33 | 3.32 | 3.32 |
| 276.72 | 3.41 | 3.41 |
| 276.72 | 3.41 | 3.41 |
| 272.30 | 2.25 | 2.25 |
| 324.40 | 4.49 | 4.49 |
| 284.31 | 2.96 | 2.96 |
| 244.29 | 3.47 | 3.47 |
| 318.80 | 4.78 | 4.78 |
| 244.29 | 3.47 | 3.47 |
| 318.80 | 4.78 | 4.78 |